Literature DB >> 30011114

Missense mutations have unexpected consequences: The McArdle disease paradigm.

Inés García-Consuegra1,2, Sara Asensio-Peña1, Alfonsina Ballester-Lopez2,3, Rosario Francisco-Velilla4, Tomás Pinos2,5, Guillem Pintos-Morell2,3,6, Jaume Coll-Cantí2,3,7, Adrián González-Quintana1, Antoni L Andreu2,5, Joaquín Arenas1,2, Alejandro Lucia8, Gisela Nogales-Gadea2,3, Miguel A Martín1,2.   

Abstract

McArdle disease is a disorder of muscle glycogen metabolism caused by mutations in the PYGM gene, encoding for the muscle-specific isoform of glycogen phosphorylase (M-GP). The activity of this enzyme is completely lost in patients' muscle biopsies, when measured with a standard biochemical test which, does not allow to determine M-GP protein levels. We aimed to determine M-GP protein levels in the muscle of McArdle patients, by studying biopsies of 40 patients harboring a broad spectrum of PYGM mutations and 22 controls. Lack of M-GP protein was found in muscle in the vast majority (95%) of patients, irrespective of the PYGM genotype, including those carrying missense mutations, with few exceptions. M-GP protein biosynthesis is not being produced by PYGM mutations inducing premature termination codons (PTC), neither by most PYGM missense mutations. These findings explain the lack of PYGM genotype-phenotype correlation and have important implications for the design of molecular-based therapeutic approaches.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  McArdle disease; genotype-phenotype correlation; missense mutations; muscle glycogen phosphorylase

Mesh:

Substances:

Year:  2018        PMID: 30011114     DOI: 10.1002/humu.23591

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  2 in total

1.  Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis.

Authors:  Inés García-Consuegra; Sara Asensio-Peña; Rocío Garrido-Moraga; Tomàs Pinós; Cristina Domínguez-González; Alfredo Santalla; Gisela Nogales-Gadea; Pablo Serrano-Lorenzo; Antoni L Andreu; Joaquín Arenas; José L Zugaza; Alejandro Lucia; Miguel A Martín
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

2.  PYGM mRNA expression in McArdle disease: Demographic, clinical, morphological and genetic features.

Authors:  Alzira A S Carvalho; Denise M Christofolini; Matheus M Perez; Beatriz C A Alves; Itatiana Rodart; Francisco W S Figueiredo; Karine C Turke; David Feder; Marcondes C F Junior; Ana M Nucci; Fernando L A Fonseca
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.